American Medical Association Calls Obesity A Disease (ARNA) (VVUS)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rebounds, but yield surge sets stage for weekly losses
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
- SpaceX shares fall as second lockup period ends
Bill for Medicare Coverage, AMA Designation Positive for Obesity Drug Makers (ARNA) (VVUS) (OREX) - Leerink Swann
June 19, 2013 12:23 PM EDTLeerink Swann analyst Marko Kozul made positive comments on obesity drug makers Arena Pharmaceuticals (NASDAQ: ARNA), VIVUS (NASDAQ: VVUS) and Orexigen (NASDAQ: OREX) intra-day Wednesday, saying he sees meaningful trends developing in... More
